It is considered investigational, which is precisely why medical supervision is essential before considering it
GLP-1 medicines are started low and stepped up deliberately: for Wegovy, 0.25 mg for weeks 1 to 4, then 0.5 mg, 1 mg, 1.7 mg, reaching the 2.4 mg maintenance dose at week 16
They are intended to be used in food, beverage, cosmetic, pharmaceutical applications or/and to help maintain & support a healthy lifestyle
Its the weight loss doing the work, not some direct anti-inflammatory mechanism
PeRx removes that step entirely
Stability Comparison Storage Requirements by Type The fragility of first-generation GHK-CU explains why proper storage matters so much for this particular peptide